Financial Performance - For the three months ended June 30, 2023, the group's revenue was approximately HKD 58.2 million, compared to HKD 44.0 million for the same period in 2022, representing a year-on-year increase of 32.3%[12] - The group generated a net profit of approximately HKD 1.3 million for the three months ended June 30, 2023, up from HKD 1.0 million in the same period of 2022, reflecting a growth of 30%[12] - The total comprehensive income for the period was HKD 1.27 million, compared to HKD 1.01 million in the same period of 2022, reflecting a growth of 25.9%[14] - Basic earnings per share for the three months ended June 30, 2023, were HKD 0.16, compared to HKD 0.13 for the same period in 2022, representing a growth of 23.1%[14] - The company's revenue from training services was HKD 57.3 million, up from HKD 42.8 million in the previous year, reflecting a growth of 33.9%[45] Costs and Expenses - The cost of goods sold for the three months ended June 30, 2023, was HKD 7.42 million, compared to HKD 7.13 million in the same period of 2022, indicating an increase of 4.1%[14] - Employee costs rose to HKD 22.95 million for the three months ended June 30, 2023, from HKD 16.29 million in the same period of 2022, marking a significant increase of 40.5%[14] - Other expenses for the same period amounted to approximately HKD 13.0 million, compared to HKD 9.4 million in 2022, driven by increased promotional activities[99] - Depreciation expenses for property, plant, and equipment were approximately HKD 6.7 million for the three months ended June 30, 2023, compared to HKD 6.0 million in 2022, due to new acquisitions[97] Dividends and Shareholder Information - The board of directors did not recommend the distribution of dividends for the three months ended June 30, 2023, consistent with the previous year[12] - The company did not declare any dividends for the three months ended June 30, 2023, consistent with the previous year[53] - As of June 30, 2023, the executive directors hold 514,500,000 shares, representing a 64.31% equity stake in the company[118] - No share options have been granted, exercised, or cancelled under the share option scheme since its adoption, and there are no unexercised options as of June 30, 2023[124] Strategic Initiatives - The group continues to focus on expanding its service offerings and product sales in Hong Kong, aiming for further growth in the upcoming quarters[12] - The company opened new flagship centers in Mong Kok and Tsim Sha Tsui to expand its operational scale and enhance market penetration[60] - The company plans to continue expanding its medical beauty center network strategically to attract a more diverse customer base[60] - The company aims to leverage its strong customer base and reputation to drive steady business growth and maximize shareholder value in the future[62] Compliance and Governance - The company has adopted the trading compliance standards as per GEM Listing Rules sections 5.48 to 5.67, confirming compliance for the three months ending June 30, 2023[104] - The Audit Committee, consisting of three independent non-executive directors, reviewed the unaudited consolidated performance for the three months ending June 30, 2023, and found it compliant with applicable accounting standards and GEM Listing Rules[106] - The company has established an Audit Committee to oversee financial reporting and internal controls, ensuring transparency and compliance[106] Market Outlook - The company believes the outlook for the medical beauty services industry remains optimistic due to increasing public acceptance and demand for these services[76] - The management will closely monitor market conditions and strengthen strategies for sustainable development to seize opportunities in the current environment[78] Other Information - Other income for the three months ended June 30, 2023, was approximately HKD 0.1 million, a decrease from HKD 2.3 million in the same period of 2022, primarily due to the absence of government subsidies received in the prior year[64] - The company completed the sale of its subsidiary for a total consideration of approximately HKD 23.07 million on July 6, 2023[83] - The company did not purchase, sell, or redeem any of its listed securities during the three months ending June 30, 2023[116] - There were no arrangements made for directors to acquire shares or debt securities of the company or any other corporation during the reporting period[126] - The company has not disclosed any new strategies or market expansions in the current report[127] - The company has not reported any new product developments or technological advancements in the current quarter[127]
亮晴控股(08603) - 2024 Q1 - 季度财报